New developments: gastroenterology.
Hillemeier
C
C
C. S. Mott Children's Hospital, University of Michigan Medical Center, Ann Arbor.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects; D005260:Female; D005762:Gastroenterology / Q000639:trends*; D016174:Hepacivirus / Q000302:isolation & purification; D006506:Hepatitis A / Q000382:microbiology; D006509:Hepatitis B / Q000382:microbiology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D012460:Sulfasalazine / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D015122:Mercaptopurine; D001379:Azathioprine